Sign in

CIK 0001783183 · Non-accelerated filer<br>Smaller reporting company

Phathom Pharmaceuticals, Inc.

Sign in to watch
Ticker
PHAT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
824151574
Phone
(877) 742-8466
Business address
100 CAMPUS DRIVE,, SUITE 102, FLORHAM PARK, NJ, 07932
  1. 4 Grant or award Director acquired 10,500 shares (grant or award)
  2. 4 Open-market buy Director bought 3,780 shares at $3.86 ($14,609)
  3. 4 Derivatives Options or other derivatives
  4. 4 Open-market buy Director bought 7,420 shares at an average $3.30 ($24,462)
  5. 4 Open-market buy Director bought 48,203 shares at an average $3.17 ($152,917)
  6. 4 Open-market buy Director bought 10,000 shares at an average $2.50 ($24,985)
  7. 3 Insider Initial Statement of Ownership
  8. 4 Grant or award Director acquired 21,000 shares (grant or award)
  9. 3 Insider Initial Statement of Ownership
  10. 4 Open-market sale CFO and CBO sold 3,678 shares at $4.55 ($16,740)
  11. 4 Derivatives Options or other derivatives
  12. 3 Insider Initial Statement of Ownership
  13. 4 Option exercise Director acquired 7,500 shares (option exercise)
  14. 4 Open-market buy Director bought 10,000 shares at $4.42 ($44,200)
  15. 4 Derivatives Options or other derivatives
  16. 4 Grant or award CFO and CBO acquired 72,000 shares (grant or award)
  17. 4 Grant or award Chief Operating Officer acquired 79,200 shares (grant or award)
  18. 4 Open-market sale CFO and CBO sold 6,583 shares at $6.59 ($43,371)
  19. 4 Open-market sale Chief Operating Officer sold 7,886 shares at $6.59 ($51,957)
  20. 4 Open-market sale President and Chief Executive sold 19,109 shares at $6.59 ($125,884)

Page 3 of 12 · 224 filings